JP2022532965A5 - - Google Patents

Info

Publication number
JP2022532965A5
JP2022532965A5 JP2021527899A JP2021527899A JP2022532965A5 JP 2022532965 A5 JP2022532965 A5 JP 2022532965A5 JP 2021527899 A JP2021527899 A JP 2021527899A JP 2021527899 A JP2021527899 A JP 2021527899A JP 2022532965 A5 JP2022532965 A5 JP 2022532965A5
Authority
JP
Japan
Prior art keywords
protein preparation
aqueous high
preparation according
concentration
concentration protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021527899A
Other languages
English (en)
Japanese (ja)
Other versions
JP7637618B2 (ja
JP2022532965A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062596 external-priority patent/WO2020106948A1/en
Publication of JP2022532965A publication Critical patent/JP2022532965A/ja
Publication of JP2022532965A5 publication Critical patent/JP2022532965A5/ja
Application granted granted Critical
Publication of JP7637618B2 publication Critical patent/JP7637618B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021527899A 2018-11-21 2019-11-21 高濃度タンパク質製剤 Active JP7637618B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862770337P 2018-11-21 2018-11-21
US62/770,337 2018-11-21
PCT/US2019/062596 WO2020106948A1 (en) 2018-11-21 2019-11-21 High concentration protein formulation

Publications (3)

Publication Number Publication Date
JP2022532965A JP2022532965A (ja) 2022-07-21
JP2022532965A5 true JP2022532965A5 (https=) 2022-11-28
JP7637618B2 JP7637618B2 (ja) 2025-02-28

Family

ID=68916589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021527899A Active JP7637618B2 (ja) 2018-11-21 2019-11-21 高濃度タンパク質製剤

Country Status (14)

Country Link
US (2) US12036280B2 (https=)
EP (1) EP3883542A1 (https=)
JP (1) JP7637618B2 (https=)
KR (1) KR102944691B1 (https=)
CN (1) CN113164378A (https=)
AU (1) AU2019384160B2 (https=)
BR (1) BR112021009463A2 (https=)
CA (1) CA3118306A1 (https=)
EA (1) EA202191403A1 (https=)
IL (1) IL283229B2 (https=)
MX (1) MX2021005910A (https=)
SG (1) SG11202104166QA (https=)
WO (1) WO2020106948A1 (https=)
ZA (1) ZA202102816B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK4364724T3 (da) 2018-05-10 2025-12-22 Regeneron Pharma Formuleringer med høj koncentration af VEGF-receptorfusionsprotein
CN120241997A (zh) 2019-02-18 2025-07-04 伊莱利利公司 治疗性抗体制剂
CA3231500A1 (en) * 2021-09-09 2023-03-16 Xeris Pharmaceuticals, Inc. Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof
IL326704A (en) * 2023-08-24 2026-04-01 Rezolute Inc High-concentration anti-insulin receptor antibody formulations and their uses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1142172B (it) * 1978-10-19 1986-10-08 Sandoz Ag Nuovo impiego in terapeutica della ciclosporina-a e della diidrociclosporina-c
US6629949B1 (en) 2000-05-08 2003-10-07 Sterling Medivations, Inc. Micro infusion drug delivery device
US6659982B2 (en) 2000-05-08 2003-12-09 Sterling Medivations, Inc. Micro infusion drug delivery device
CA2418960A1 (en) * 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
US20090208492A1 (en) * 2007-06-14 2009-08-20 Elan Pharmaceuticals, Inc. Lyophilized Immunoglobulin Formulations and Methods of Preparation
US9072668B2 (en) * 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
CA2829629A1 (en) * 2011-03-10 2012-09-13 Board Of Regents, The University Of Texas System Protein nanoparticle dispersions
CN103356490A (zh) * 2012-03-29 2013-10-23 复旦大学 可直接固体化的交联食物蛋白稳定化纳米给药系统
EP2849723B1 (en) * 2012-05-18 2018-05-02 Genentech, Inc. High-concentration monoclonal antibody formulations
UA117466C2 (uk) * 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
IL312865B2 (en) * 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
PL2942050T3 (pl) * 2014-05-06 2023-01-09 S.I.I.T. S.R.L.-Servizio Internazionale Imballaggi Termosaldanti Nadająca się do rozpylania olejowa kompozycja oparta na rozpuszczalnych w tłuszczach witaminach z grupy d oraz jej zastosowanie
WO2016109822A1 (en) * 2014-12-31 2016-07-07 Novelmed Therapeutics, Inc. Formulation of aglycosylated therapeutic antibodies
EP3522918A1 (en) * 2016-10-06 2019-08-14 Amgen Inc. Reduced viscosity protein pharmaceutical formulations

Similar Documents

Publication Publication Date Title
JP2022532965A5 (https=)
JP5414542B2 (ja) ビタミンｄおよびコルチコステロイドを有するポリアフロン局所組成物
AU2005294805B2 (en) A mixture for transdermal delivery of low and high molecular weight compounds
EP2391344B1 (en) Compositions for nail and skin treatment
JP6042343B2 (ja) 毛髪成長のための組成物及び方法
RU2015131700A (ru) Фармацевтические композиции, включающие производное камптотецина
FR2851470A1 (fr) Composition pharmaceutique pour administration transdermique ou transmuqueuse
FI3360575T3 (fi) Ihon kautta annosteltavat farmaseuttiset koostumukset, jotka käsittävät vaikuttavia aineita
NL2003786C2 (en) COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
JP2013508296A5 (https=)
FR3076456A1 (fr) Huiles capillaires pour le traitement de fibres keratiniques
WO2014042043A1 (en) Pharmaceutical composition containing luliconazole
JP2017503866A (ja) デュタステリドを含む自己乳化型薬物送達システムのための組成物
KR20110027838A (ko) 광선 각화증을 치료하기 위한 국소 조성물
AR043106A2 (es) Formulaciones farmaceuticas para la administracion oral y topica y formas de dosis farmaceutica
ES2661106T3 (es) Formulaciones de crema estabilizadas que comprenden aceite de sándalo
MXPA05002077A (es) Composicion topica de gel en emulsion que comprende diclofenaco-sodio.
US9427404B2 (en) Microemulsion preconcentrates and microemulsions, and preparation processes of the same
MX2021007393A (es) Formulacion de solucion de proteinas que contiene una alta concentracion de un anticuerpo anti-vegf.
ES2519240A2 (es) Preparación de caspofungina de bajo contenido de impurezas, método para preparar la misma, y uso de la misma
JPH10139661A (ja) 新規な治療用抗炎症鎮痛医薬組成物およびその製造法
CA2566354C (en) A mixture for transdermal delivery of low and high molecular weight compounds
DK3122323T3 (en) Formulation for personal hygiene
FR2871700A1 (fr) Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR3089815A1 (fr) Agents cosmétiques destinés au conditionnement des fibres kératiniques